1. Home
  2. DLHC vs FBIO Comparison

DLHC vs FBIO Comparison

Compare DLHC & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DLH Holdings Corp.

DLHC

DLH Holdings Corp.

HOLD

Current Price

$5.55

Market Cap

80.6M

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$3.34

Market Cap

88.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLHC
FBIO
Founded
1969
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.6M
88.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DLHC
FBIO
Price
$5.55
$3.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
29.9K
491.9K
Earning Date
02-04-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$344,497,000.00
$62,303,000.00
Revenue This Year
N/A
$29.71
Revenue Next Year
N/A
$49.34
P/E Ratio
$62.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.72
$1.33
52 Week High
$8.45
$4.20

Technical Indicators

Market Signals
Indicator
DLHC
FBIO
Relative Strength Index (RSI) 37.83 67.88
Support Level $5.50 $2.49
Resistance Level $5.65 $3.75
Average True Range (ATR) 0.18 0.21
MACD -0.07 0.07
Stochastic Oscillator 6.17 69.57

Price Performance

Historical Comparison
DLHC
FBIO

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: